SA
Sign upLog In

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)

Total Costs & Expenses

$2.44M

Quarterly · Period ending: · USD

CANF logo

CANF Total Costs & Expenses

Latest reported$2.44M
CANF Quarterly Total Costs & Expenses ($1.00M → $2.44M)
High-resolution chart · PNG

CANF total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
2,441,000
2,441,000
2,627,500
2,627,500
2,550,000
2,550,000
2,196,999
2,196,999
2,205,000
2,205,000
1,989,000
2,061,000
1,980,000
2,908,000
3,280,000
2,777,000
2,274,000
2,575,000
4,232,000
3,761,000
3,383,000
2,319,000
3,703,000
2,690,000
4,035,000
4,474,000
4,799,000
3,943,000
3,283,000
2,010,000
2,792,000
1,985,000
2,237,000
2,220,000
2,503,251
1,754,725
1,946,367
2,016,106
2,590,214
2,332,378
2,177,058
1,703,706
2,412,631
1,410,008
1,542,967
1,214,115
1,659,658
1,376,615
2,163,086
1,933,022
3,444,701
1,551,573
2,181,993
1,722,665
2,088,176
1,201,567
1,241,972
1,578,798
1,293,911
1,168,566
1,393,419
1,637,630
1,273,512
1,002,185
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.